Trial intelligence / Profile preview

Tranexamic acid for reducing hemorrhage in spinal surgery

ChiCTR2000033597Phase 4Recruiting

Sponsor
People's Hospital of Xinjiang Uyghur Autonomous Region
Start
Jun 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of tranexamic acid in degenerative spinal conditions (2 arms), sponsored by People's Hospital of Xinjiang Uyghur Autonomous Region. Primary endpoints: Blood routine index, Blood coagulation index and 4 more. Started Jun 2020; status: recruiting.

02

Drugs

tranexamic acid
03

Conditions

degenerative spinal conditions

Beyond the preview

Go deeper on ChiCTR2000033597.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000033597.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call